Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
Top Cited Papers
Open Access
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (2) , 259-266
- https://doi.org/10.1023/a:1008382516636
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Phase II study on cisplatin and ifosfamide in recurrent high grade gliomasEuropean Journal Of Cancer, 1998
- The charing cross hospital experience with temozolomide in patients with gliomasEuropean Journal Of Cancer, 1996
- A phase II study of intravenous carboplatin for the treatment of recurrent gliomasJournal of Neuro-Oncology, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumoursEuropean Journal Of Cancer, 1993
- Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failureJournal of Neuro-Oncology, 1992
- Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA)Journal of Neuro-Oncology, 1991
- Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failureNeurology, 1990
- Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicityCancer Chemotherapy and Pharmacology, 1990